Login / Signup
Shivanshan Pathmanathan
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Gestational Age
Randomized Controlled Trial
Ejection Fraction
Free Survival
Top Venues
Pigment cell & melanoma research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shivanshan Pathmanathan
,
Hari Babu
,
Marcin Dzienis
,
Mary Azer
,
Melissa Eastgate
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis.
Pigment cell & melanoma research
35 (6) (2022)